Form D · Biotechnology
IFM Tre, Inc.
Boston, MA · CIK 0001747596
Offering snapshot reported Aug 2, 2018 · SEC filing
- Reported sold
- $22M Indefinite offering
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 18, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 2, 2018 | Initial | $22,000,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-318362
Source: Form D, filed Aug 2, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jean Francois Formela | Director |
| Gary D Glick | Director, Executive |
| Vincent Miles | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
855 Boylston Street, 11 Th Floor
Boston, MA, 02116
Boston, MA, 02116